Earnings Feed
Start Free
Home/Filings/4/0001140361-08-020337
4//SEC Filing

Kang Y Michele 4

Accession 0001140361-08-020337

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 4:51 PM ET

Size

10.8 KB

Accession

0001140361-08-020337

Insider Transaction Report

Form 4
Period: 2008-06-30
REXAHN PHARMACEUTICALS, INC.RXHN.OB
Kang Y Michele
Director
Transactions
  • Award

    Stock Options (right to buy)

    2008-06-30+20,000→ 20,000 total
    Exercise: $3.24Exp: 2018-06-30→ Common Stock (20,000 underlying)
  • Award

    Stock Options (right to buy)

    2008-08-12+150,000→ 150,000 total
    Exercise: $1.47Exp: 2018-08-12→ Common Stock (150,000 underlying)
Holdings

  • Stock Options (right to buy)

    Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]These options vest and become exercisable in full on June 30, 2009.
  • [F2]30% of the options vest and become exercisable on August 12, 2009; another 30% of the options vest and become exercisable on August 12, 2010; and the remaining 40% of the options vest and became exercisable on August 12, 2011.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001361685

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:51 PM ET
Size
10.8 KB
View on SEC.gov